The estimated Net Worth of Lawrence Waldman is at least $225 Thousand dollars as of 12 July 2023. Mr. Waldman owns over 5,338 units of Apyx Medical stock worth over $6,726 and over the last 9 years he sold APYX stock worth over $0. In addition, he makes $218,368 as Lead Independent Director at Apyx Medical.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mr. Waldman APYX stock SEC Form 4 insiders trading
Lawrence has made over 5 trades of the Apyx Medical stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 5,338 units of APYX stock worth $15,854 on 12 July 2023.
The largest trade he's ever made was exercising 24,000 units of Apyx Medical stock on 11 July 2022 worth over $60,960. On average, Lawrence trades about 1,474 units every 65 days since 2015. As of 12 July 2023 he still owns at least 5,338 units of Apyx Medical stock.
You can see the complete history of Mr. Waldman stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Lawrence Waldman biography
Lawrence J. Waldman CPA serves as Lead Independent Director of the Company. Mr. Waldman has over thirty-five years of experience in public accounting. Mr. Waldman currently serves as a senior advisor to First Long Island Investors, LLC, an investment and wealth management firm since May 2016. Prior to that Mr. Waldman served as an advisor to the accounting firm of EisnerAmper LLP, where he was previously the Partner-in-Charge of Commercial Audit Practice Development for Long Island since September 2011. Prior to joining EisnerAmper LLP, Mr. Waldman was the Partner-in-Charge of Commercial Audit Practice Development for Holtz Rubenstein Reminick, LLP from July 2006 to August 2011. Mr. Waldman was the Managing Partner of the Long Island office of KPMG LLP from 1994 through 2006, the accounting firm where he began his career in 1972. Mr. Waldman was elected to the Board of Directors of Comtech Telecommunications Corp. in August of 2015 and since December 2015, serves as Chair of its audit committee. In October 2016, Mr. Waldman was appointed and subsequently in December 2016 elected to the Board of Directors of CVD Equipment Corporation, and serves as the Chair of the audit committee and as Lead Independent Director Mr. Waldman served through October 2018 as a member of the Board of Directors of Northstar/ RXR Metro Income Fund, a non-traded Real Estate Investment Trust and has served as a member of its audit committee since
What is the salary of Lawrence Waldman?
As the Lead Independent Director of Apyx Medical, the total compensation of Lawrence Waldman at Apyx Medical is $218,368. There are 8 executives at Apyx Medical getting paid more, with Charles Goodwin having the highest compensation of $1,945,260.
How old is Lawrence Waldman?
Lawrence Waldman is 73, he's been the Lead Independent Director of Apyx Medical since 2011. There are 2 older and 10 younger executives at Apyx Medical. The oldest executive at Apyx Medical Corporation is Andrew Makrides, 78, who is the Independent Chairman of the Board.
What's Lawrence Waldman's mailing address?
Lawrence's mailing address filed with the SEC is C/O APYX MEDICAL CORPORATION, 5115 ULMERTON ROAD, CLEARWATER, FL, 33760.
Insiders trading at Apyx Medical
Over the last 6 years, insiders at Apyx Medical have traded over $0 worth of Apyx Medical stock and bought 97,836 units worth $253,260 . The most active insiders traders include Stavros G. Vizirgianakis, Charles D. Ii Goodwin, and Moshe Citronowicz. On average, Apyx Medical executives and independent directors trade stock every 86 days with the average trade being worth of $18,719. The most recent stock trade was executed by Matthew C Hill on 13 August 2024, trading 5,336 units of APYX stock currently worth $6,030.
What does Apyx Medical do?
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and OEM. It offers electrosurgical generators based on its Helium Plasma Technology for cutting, coagulation, and ablation of soft tissue. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market that allows surgeons to operate with precision and eliminate unintended tissue trauma. It also develops, manufactures, and sells energy generators, disposable hand piece subassemblies, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
What does Apyx Medical's logo look like?
Complete history of Mr. Waldman stock trades at Comtech Telecommunications, CVD Equipment, and Apyx Medical
Apyx Medical executives and stock owners
Apyx Medical executives and other stock owners filed with the SEC include:
-
Charles Goodwin,
Chief Executive Officer, Director -
Todd Hornsby,
Executive Vice President -
Moshe Citronowicz,
Senior Vice President -
Tara Semb,
Chief Financial Officer, Treasurer, Secretary -
Charles D. Goodwin II,
Pres, CEO & Director -
Todd Hornsby,
Exec. VP -
Tara H. Semb,
CFO, Treasurer & Sec. -
Moshe Citronowicz,
Sr. VP -
Lawrence Waldman,
Lead Independent Director -
John Andres,
Independent Vice Chairman of the Board -
Andrew Makrides,
Independent Chairman of the Board -
Michael Geraghty,
Independent Director -
Craig Swandal,
Independent Director -
Minnie Baylor-Henry,
Independent Director -
Wendy Lauren Levine,
Director -
Matthew C Hill,
Chief Financial Officer -
Stavros G. Vizirgianakis,
Director